Jones D A, Fitzpatrick F A, Malcolm K C
Department of Pharmacology, University of Colorado Health Sciences Center, Denver 80262.
Biochem Biophys Res Commun. 1991 Oct 15;180(1):8-14. doi: 10.1016/s0006-291x(05)81247-1.
Human erythroleukemia cells transformed arachidonic acid and prostaglandin endoperoxide H2 into thromboxane A2. Stimulation of these cells with A23187 or thrombin, however, produced no thromboxane. Similarly, cells labeled with [3H]-arachidonic acid released no detectable label upon stimulation. Data suggest that human erythroleukemia cells contain the enzymatic capacity for thromboxane formation from exogenous precursors, but lack the endogenous mechanisms for arachidonate release. The presence of thromboxane synthase messenger RNA was verified using the polymerase chain reaction. Amplification and sequence analysis of a 528 bp cDNA demonstrated virtually 100% identity to a published thromboxane synthase cDNA fragment.
人红白血病细胞可将花生四烯酸和前列腺素内过氧化物H2转化为血栓素A2。然而,用A23187或凝血酶刺激这些细胞并不会产生血栓素。同样,用[3H] - 花生四烯酸标记的细胞在受到刺激后也未释放出可检测到的标记物。数据表明,人红白血病细胞具有将外源性前体物质形成血栓素的酶促能力,但缺乏花生四烯酸释放的内源性机制。使用聚合酶链反应验证了血栓素合酶信使RNA的存在。对一个528 bp的cDNA进行扩增和序列分析,结果显示其与已发表的血栓素合酶cDNA片段几乎100%相同。